April 16, 2025 Nvidia’s $5.5B AI Chip Crunch and ASML’s Tariff Jitters
Apple: Dividend Growth Ahead, But a Near-Term Slide Likely
April 23, 2025 Oleksandr Orlovskyi: Reviews, Biography, and All About Cryptocurrency
March 12, 2025 Features of exchanging USDC ERC20 to Bank Transfer
February 19, 2025 Why Stock Caps Matter When Building a Diversified Portfolio
February 5, 2025 Top 5 Coins for the Maximum Passive Income from Staking by 2024
January 21, 2025 Trading Stocks With AI: A Modern Approach
Aridis Pharmaceuticals (ARDS) Stock Forecast for 2025, 2026, 2027. Sell or Buy?
Updated: April 29, 2025 (18:43)
Sector: HealthcareThe share price of Aridis Pharmaceuticals, Inc. (ARDS) now
Are you interested in Aridis Pharmaceuticals, Inc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Aridis Pharmaceuticals stock price in 2025, 2026, 2027. How much will one Aridis Pharmaceuticals share be worth in 2025 - 2027?
When should I take profit in Aridis Pharmaceuticals stock? When should I record a loss on Aridis Pharmaceuticals stock? What are analysts' forecasts for Aridis Pharmaceuticals stock? What is the future of Aridis Pharmaceuticals stock? We forecast Aridis Pharmaceuticals stock performance using neural networks based on historical data on Aridis Pharmaceuticals stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.
Aridis Pharmaceuticals stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2025, 2026, 2027, and ) The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for Aridis Pharmaceuticals shares. This happens once a day.
Historical and forecast chart of Aridis Pharmaceuticals stock
The chart below shows the historical price of Aridis Pharmaceuticals stock and a prediction chart for the next month.
For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast,
and Weighted Average Best Forecast. Detailed values for the Aridis Pharmaceuticals stock price can be found in the table below.
Long-term forecasts by years.
Aridis Pharmaceuticals, Inc. Is a biopharmaceutical company specializing in the discovery and development of targeted immunotherapy using fully human monoclonal antibodies (mAbs) to treat infections. MABs represent a treatment approach that allows the human immune system to fight infections and is designed to overcome the disadvantages associated with current therapies, such as increased drug resistance, short response times, negative effects on the human microbiome, and lack of differentiation between treatment alternatives. Its product pipeline includes human MABs that target specific pathogens associated with bacterial infections, most notably hospital-acquired pneumonia (HAP) and ventilator-associated pneumonia (VAP). Its leading candidate product, AR-301, targets the alpha toxin produced by the gram-positive bacteria Staphylococcus aureus, a common pathogen associated with HAP and VAP. Its AR-101 (Aerumab) is a fully human immunoglobulin M targeting P. aeruginosa serotype O11.
Aridis Pharmaceuticals daily forecast for a month
| Date | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| May 01 | 0.00 | 0.00 | 0.00 | 94.12 |
| May 02 | 0.00 | 0.00 | 0.00 | 59.80 |
| May 03 | 0.00 | 0.00 | 0.00 | 44.60 |
| May 04 | 0.00 | 0.00 | 0.00 | 127.22 |
| May 05 | 0.00 | 0.00 | 0.00 | 105.72 |
| May 06 | 0.00 | 0.00 | 0.00 | 30.78 |
| May 07 | 0.00 | 0.00 | 0.00 | 107.22 |
| May 08 | 0.00 | 0.00 | 0.00 | 106.40 |
| May 09 | 0.00 | 0.00 | 0.00 | 134.35 |
| May 10 | 0.00 | 0.00 | 0.00 | 76.08 |
| May 11 | 0.00 | 0.00 | 0.00 | 96.76 |
| May 12 | 0.00 | 0.00 | 0.00 | 96.02 |
| May 13 | 0.00 | 0.00 | 0.00 | 81.28 |
| May 14 | 0.00 | 0.00 | 0.00 | 121.84 |
| May 15 | 0.00 | 0.00 | 0.00 | 85.44 |
| May 16 | 0.00 | 0.00 | 0.00 | 79.62 |
| May 17 | 0.00 | 0.00 | 0.00 | 73.74 |
| May 18 | 0.00 | 0.00 | 0.00 | 107.10 |
| May 19 | 0.00 | 0.00 | 0.00 | 59.81 |
| May 20 | 0.00 | 0.00 | 0.00 | 76.23 |
| May 21 | 0.00 | 0.00 | 0.00 | 61.11 |
| May 22 | 0.00 | 0.00 | 0.00 | 32.67 |
| May 23 | 0.00 | 0.00 | 0.00 | 62.79 |
| May 24 | 0.00 | 0.00 | 0.00 | 49.64 |
| May 25 | 0.00 | 0.00 | 0.00 | 44.18 |
| May 26 | 0.00 | 0.00 | 0.00 | 47.77 |
| May 27 | 0.00 | 0.00 | 0.00 | 103.59 |
| May 28 | 0.00 | 0.00 | 0.00 | 87.90 |
| May 29 | 0.00 | 0.00 | 0.00 | 67.66 |
| May 30 | 0.00 | 0.00 | 0.00 | 58.79 |
Aridis Pharmaceuticals Daily Price Targets
Aridis Pharmaceuticals Stock Forecast 05-01-2025.
Forecast target price for 05-01-2025: $0.00.
Positive dynamics for Aridis Pharmaceuticals shares will prevail with possible volatility of 48.485%.
Pessimistic target level: 0.00
Optimistic target level: 0.00
Aridis Pharmaceuticals Stock Forecast 05-02-2025.
Forecast target price for 05-02-2025: $0.00.
Negative dynamics for Aridis Pharmaceuticals shares will prevail with possible volatility of 37.423%.
Pessimistic target level: 0.00
Optimistic target level: 0.00
Aridis Pharmaceuticals Stock Forecast 05-03-2025.
Forecast target price for 05-03-2025: $0.00.
Positive dynamics for Aridis Pharmaceuticals shares will prevail with possible volatility of 30.845%.
Pessimistic target level: 0.00
Optimistic target level: 0.00
Aridis Pharmaceuticals Stock Forecast 05-04-2025.
Forecast target price for 05-04-2025: $0.00.
Positive dynamics for Aridis Pharmaceuticals shares will prevail with possible volatility of 55.991%.
Pessimistic target level: 0.00
Optimistic target level: 0.00
Aridis Pharmaceuticals Stock Forecast 05-05-2025.
Forecast target price for 05-05-2025: $0.00.
Negative dynamics for Aridis Pharmaceuticals shares will prevail with possible volatility of 51.390%.
Pessimistic target level: 0.00
Optimistic target level: 0.00
Aridis Pharmaceuticals Stock Forecast 05-06-2025.
Forecast target price for 05-06-2025: $0.00.
Negative dynamics for Aridis Pharmaceuticals shares will prevail with possible volatility of 23.537%.
Pessimistic target level: 0.00
Optimistic target level: 0.00
ARDS (ARDS) Monthly Stock Prediction for 2025
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| May. | 0.00 | 0.00 | 0.00 | 13.31 |
| Jun. | 0.00 | 0.00 | 0.00 | 16.26 |
| Jul. | 0.00 | 0.00 | 0.00 | 15.29 |
| Aug. | 0.00 | 0.00 | 0.00 | 15.11 |
| Sep. | 0.00 | 0.00 | 0.00 | 16.88 |
| Oct. | 0.00 | 0.00 | 0.00 | 12.83 |
| Nov. | 0.00 | 0.00 | 0.00 | 10.39 |
| Dec. | 0.00 | 0.00 | 0.00 | 16.52 |
Aridis Pharmaceuticals forecast for this year
Aridis Pharmaceuticals Stock Prediction for May 2025
An uptrend is forecast for this month with an optimal target price of $0.00010192. Pessimistic: $0.00. Optimistic: $0.00
Aridis Pharmaceuticals Stock Prediction for Jun 2025
An uptrend is forecast for this month with an optimal target price of $0.000116107. Pessimistic: $0.00. Optimistic: $0.00
Aridis Pharmaceuticals Stock Prediction for Jul 2025
An uptrend is forecast for this month with an optimal target price of $0.00012391. Pessimistic: $0.00. Optimistic: $0.00
Aridis Pharmaceuticals Stock Prediction for Aug 2025
An uptrend is forecast for this month with an optimal target price of $0.000124901. Pessimistic: $0.00. Optimistic: $0.00
Aridis Pharmaceuticals Stock Prediction for Sep 2025
An downtrend is forecast for this month with an optimal target price of $0.000116707. Pessimistic: $0.00. Optimistic: $0.00
Aridis Pharmaceuticals Stock Prediction for Oct 2025
An uptrend is forecast for this month with an optimal target price of $0.000131833. Pessimistic: $0.00. Optimistic: $0.00
Aridis Pharmaceuticals Stock Prediction for Nov 2025
An uptrend is forecast for this month with an optimal target price of $0.000133731. Pessimistic: $0.00. Optimistic: $0.00
Aridis Pharmaceuticals Stock Prediction for Dec 2025
An uptrend is forecast for this month with an optimal target price of $0.000143788. Pessimistic: $0.00. Optimistic: $0.00
Aridis Pharmaceuticals (ARDS) Monthly Stock Prediction for 2026
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan | 0.00 | 0.00 | 0.00 | 22.19 |
| Feb | 0.00 | 0.00 | 0.00 | 16.23 |
| Mar | 0.00 | 0.00 | 0.00 | 18.43 |
| Apr | 0.00 | 0.00 | 0.00 | 21.28 |
| May | 0.00 | 0.00 | 0.00 | 15.66 |
| Jun | 0.00 | 0.00 | 0.00 | 21.79 |
| Jul | 0.00 | 0.00 | 0.00 | 21.06 |
| Aug | 0.00 | 0.00 | 0.00 | 13.86 |
| Sep | 0.00 | 0.00 | 0.00 | 11.43 |
| Oct | 0.00 | 0.00 | 0.00 | 15.38 |
| Nov | 0.00 | 0.00 | 0.00 | 16.42 |
| Dec | 0.00 | 0.00 | 0.00 | 14.56 |
Aridis Pharmaceuticals (ARDS) Monthly Stock Prediction for 2027
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan | 0.00 | 0.00 | 0.00 | 10.27 |
| Feb | 0.00 | 0.00 | 0.00 | 19.91 |
| Mar | 0.00 | 0.00 | 0.00 | 15.03 |
| Apr | 0.00 | 0.00 | 0.00 | 19.91 |
| May | 0.00 | 0.00 | 0.00 | 14.66 |
| Jun | 0.00 | 0.00 | 0.00 | 10.17 |
| Jul | 0.00 | 0.00 | 0.00 | 17.57 |
| Aug | 0.00 | 0.00 | 0.00 | 21.18 |
| Sep | 0.00 | 0.00 | 0.00 | 19.42 |
| Oct | 0.00 | 0.00 | 0.00 | 11.89 |
| Nov | 0.00 | 0.00 | 0.00 | 18.86 |
| Dec | 0.00 | 0.00 | 0.00 | 20.31 |
Aridis Pharmaceuticals information and performance
N/A
Market capitalization of the Aridis Pharmaceuticals, Inc. is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of ARDS shares in the company outstanding by the market price of one share.
EBITDA of Aridis Pharmaceuticals is earnings before interest, income tax and depreciation of assets.
P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit
Price/earnings to growth
Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.
Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.
EPS shows how much of the net profit is accounted for by the common share.
Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.
Forward P/E uses projections of future earnings instead of final numbers.
Enterprise Value (EV) /Revenue
The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).
Number of issued ordinary shares
Number of freely tradable shares
Shares Short Prior Month - the number of shares in short positions in the last month.
FAQ (Frequently Asked Questions about Aridis Pharmaceuticals Stock)
Should I Buy Aridis Pharmaceuticals Shares in 2025 year?
Does Aridis Pharmaceuticals pay dividends?
Which economic sector do Aridis Pharmaceuticals's shares belong to?
Which other securities belong to the same sector as Aridis Pharmaceuticals's shares?
